﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/fda-public-health-advisory-fda-announces-important-changes-and-additio/447354/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/cox-2-selective-and-non-selective-non-steroidal-anti-inflammatory-drug/447355/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/questions-and-answers-on-cox-2-selective-and-non-selective-non-steroid/447356/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/drug-approvals-for-february-2002/447358/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/the-best-way-to-take-your-over-the-counter-pain-reliever-seriously/447359/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/meloxicam-marketed-as-mobic-consumer-information-sheet/447360/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/fda-alert-for-healthcare-professionals-ibuprofen-and-aspirin/447361/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/fda-alerts/drug-approval-package-020499-actron/447357/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/news-articles/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/msn/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/msn/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/thank-you.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/disclaimer.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/ContactUs.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/local/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/actron/local/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
